That would result in a lower rate of CXCL13-directed B-cell migration to secondary lymphoid organs, reduced CNS infiltration and reduced rate of meningeal B-cell follicles formation (33), providing a possible mechanistic explanation for the low risk of MS progression associated with the rs630923 minor allele. The gene discussed is CXCL13; the disease is myeloid sarcoma.